Spots Global Cancer Trial Database for Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
Official Title: Tempus Small Cell Lung Cancer Observational Study (Sculptor): A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays
Study ID: NCT05257551
Conditions
Interventions
Study Description
Brief Summary: The study is a non-interventional evaluation of participants with SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA biomarker profiling in addition to their standard of care therapy and disease surveillance.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
University of Colorado, Aurora, Colorado, United States
Illinois Cancer Care, Peoria, Illinois, United States
Johns Hopkins University, Baltimore, Maryland, United States
Englewood Health Medical Center, Englewood, New Jersey, United States
University of North Carolina, Chapel Hill, North Carolina, United States
TriHealth Cancer Institute, Cincinnati, Ohio, United States
OhioHealth Research Institute, Columbus, Ohio, United States
Oklahoma Cancer Specialists and Research Institutes, Tulsa, Oklahoma, United States
Cancer Care Association of York, York, Pennsylvania, United States
Contact Details
Name: Virginia Rhodes, MD
Affiliation: Tempus AI, Inc.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
